Clearly presenting information back to patients: Patients involved in clinical trials deserve to have a ... content and electronic informed consent sheets that respectfully explain concepts ...

FDA acknowledges that the benefit of repeat doses of COVID-19 vaccine boosters for Americans is uncertain; the updated regulatory framework for COVID-19 vaccines articulated by th ...

Corporate and Financial Updates In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet ...

Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.

Q1 2025 Earnings Call Transcript May 15, 2025 Omeros Corporation misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.57. Jennifer Williams – Investor and Media relations ...

At March 31, 2025, Celcuity reported cash, cash equivalents and short-term investments of $205.7 million. We expect cash, ...

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

Patient involvement is key ... These must be submitted into the Clinical Trials Information System (CTIS), part of the EU Database, portal, no later than 12 months after the protocol-defined ...

Omeros Corp Earnings Call ...

Despite the unfavorable trial results, iTeos Therapeutics has initiated a strategic review to maximize shareholder value. The company’s CEO, Michel Detheux, Ph.D., expressed disappointment over the ...